EsoSure's Remarkable Story

  The EsoSure Story - What are the odds?

 

     In 2005 the EsoSure Esophageal Retractor was invented by an EP nurse, Steve Miller, after a patient in his department was diagnosed and treated for an injured esophagus...following his AFib Ablation. The patient spent 5 days in the ICU, was followed up aggressively, and was one of the lucky few who survived as the mortality is around 80%. 

Terrified by this complication, Steve brainstormed for a way to prevent it from happening again. A short time later he tested his idea by putting a Salem Sump gastric tube down his own throat, took a baseline fluoro image, bent a rainbow curve near the end of a .035 guidewire, inserted the wire into the OG tube, hopped back up on the fluoro table and took another image.

It worked.  The esophagus moved laterally.  His EP Lab used contrast to monitor the esophagus in their procedures and they frequently saw the esophagus move by itself.  The wire simply mimicked physiologic migration, making it very safe.

Taking drawings, sample wires, and his idea to a local patent attorney's office, Steve waited at the conference table.  And who was the patent attorney who sat down on the other side of the table? ...his patient whose esophagus had been damaged and who could have died without early diagnosis and aggressive treatment.

 

EsoSure, Steve Miller, esophageal retractor, esophagus, afib, atrioesophageal fistula, move the esophags, deviate the esphagus

17 EsoSure’s were tested in Steve Miller’s own

esophagus to be sure it was safe and effective to use.

After ten years of patent work, FDA hurdles, testing on cadavers, two animal studies (at a very famous research facility), researching, redesigning, looking for a company to help take the final steps, self inserting 4 more OG tubes and testing 15+ additional retractors, the EsoSure has been available for 4 years and used over 14,000 times. 

1313 W. Boynton Beach Blvd 1B #393

Boynton Beach, FL 33426

esosure@epreward.com

Fax: 561-375-7927

  • Facebook
  • Twitter
  • YouTube